Evaluating the Impacts of a Single Session of Robot Assisted Gait Training With a Trexo
Launched by UNIVERSITY OF CALGARY · May 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a special robotic device called the Trexo can help people with physical disabilities, such as cerebral palsy or other developmental disabilities, improve their walking abilities. The researchers want to understand the benefits of using the Trexo in different ways, such as whether it helps more when the robot does most of the work or when the person has to contribute more. Participants will have three visits: one to get fitted for the Trexo and get comfortable using it, followed by two sessions where they will try out different settings on the device. Families can choose to come for more sessions if they want to learn about other benefits, like how it affects brain activity.
To be eligible for this trial, participants should weigh less than 150 pounds and be shorter than 5 feet 7 inches. They also need to have difficulty walking due to a neurological or muscular condition. However, those who are taller or heavier than these limits, or have certain medical issues that prevent them from bearing weight, cannot participate. This study is a great opportunity to learn more about how robotic gait training can help with rehabilitation and to see if there are ways to make the device even better for users.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Able to fit into the Trexo robotic gait trainer (\<150 lbs., \<5'7").
- • Has impaired ability to walk due to a neurological or muscular disorder.
- Exclusion Criteria:
- • \>150 lbs.
- • \>5'6" tall
- • Medical contraindication to weight bearing (ie. recent orthopedic surgery)
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Elizabeth G Condliffe, MD, PhD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported